BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 8982583)

  • 1. Cytopathology of serous neoplasia of the ovary and the peritoneum: differential diagnosis from mesothelial proliferations.
    Pisharodi LR; Bedrossian CW
    Diagn Cytopathol; 1996 Nov; 15(4):292-5. PubMed ID: 8982583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Well-differentiated serous neoplasms of the ovary.
    Longacre TA; Kempson RL; Hendrickson MR
    Pathology (Phila); 1993; 1(2):255-306. PubMed ID: 9420921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillary serous carcinoma of peritoneum: case study and review of the literature on the differential diagnosis of malignant peritoneal tumors.
    Koutselini HA; Lazaris AC; Thomopoulou G; Papayannopoulou A; Kairi-Vasilatou E
    Adv Clin Path; 2001 Jul; 5(3):99-104. PubMed ID: 11753882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between serious ovarian tumors and extra-ovarian peritoneal tumors of the same histology].
    Kunz J; Rondez R
    Praxis (Bern 1994); 1998 Feb; 87(6):191-8. PubMed ID: 9531813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serous and mesothelial proliferations of the extraovarian peritoneum and pelvic lymph nodes.
    Walker AN; Mills SE
    Pathology (Phila); 1993; 1(2):411-39. PubMed ID: 9420925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pelvic washing cytology in serous borderline tumors of the ovary using ThinPrep: are there cytologic clues to detecting tumor cells?
    Sadeghi S; Ylagan LR
    Diagn Cytopathol; 2004 May; 30(5):313-9. PubMed ID: 15108228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. h-caldesmon, calretinin, estrogen receptor, and Ber-EP4: a useful combination of immunohistochemical markers for differentiating epithelioid peritoneal mesothelioma from serous papillary carcinoma of the ovary.
    Comin CE; Saieva C; Messerini L
    Am J Surg Pathol; 2007 Aug; 31(8):1139-48. PubMed ID: 17667535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum.
    Attanoos RL; Webb R; Dojcinov SD; Gibbs AR
    Histopathology; 2002 Mar; 40(3):237-44. PubMed ID: 11895489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A useful antibody panel for differential diagnosis between peritoneal mesothelioma and ovarian serous carcinoma in Japanese cases.
    Takeshima Y; Amatya VJ; Kushitani K; Inai K
    Am J Clin Pathol; 2008 Nov; 130(5):771-9. PubMed ID: 18854270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of estrogen and progesterone receptor immunostaining in distinguishing between peritoneal mesotheliomas and serous carcinomas.
    Ordóñez NG
    Hum Pathol; 2005 Nov; 36(11):1163-7. PubMed ID: 16260268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas.
    Ordóñez NG
    Am J Surg Pathol; 1998 Oct; 22(10):1203-14. PubMed ID: 9777982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serous papillary cancer of the peritoneum: a multicentric primary disease].
    Maassen V; Debus-Thiede G
    Zentralbl Gynakol; 1993; 115(8):347-54. PubMed ID: 8212940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Well-Differentiated Papillary Mesothelioma with Omental Calcifications: A Case Report and Review of the Literature.
    Erem AS; Allamaneni SS; Braverman TS
    Am J Case Rep; 2020 Jan; 21():e920487. PubMed ID: 31929500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian serous borderline tumors with noninvasive and invasive peritoneal implants: A case report each.
    Srinivasamurthy BC; Kulandai Velu AR; Krishnan N; Patil AS
    J Cancer Res Ther; 2015; 11(3):646. PubMed ID: 26458602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathology of the peritoneum: a review of selected topics.
    Daya D; McCaughey WT
    Semin Diagn Pathol; 1991 Nov; 8(4):277-89. PubMed ID: 1759060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-grade Serous Neoplasia of the Female Genital Tract.
    Folkins AK; Longacre TA
    Surg Pathol Clin; 2019 Jun; 12(2):481-513. PubMed ID: 31097112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Normal-sized ovary carcinoma syndrome--clinical and pathological analysis of 11 cases].
    Yao Z; Li L; Yang H
    Zhonghua Zhong Liu Za Zhi; 1998 Sep; 20(5):383-6. PubMed ID: 10921039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of immunohistochemistry in differentiating between peritoneal mesothelioma and ovarian serous carcinoma.
    Al-Rawi HJ; Ben-Ghashir NS
    Saudi Med J; 2009 Apr; 30(4):571-4. PubMed ID: 19370292
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary peritoneal serous borderline tumors.
    Hutton RL; Dalton SR
    Arch Pathol Lab Med; 2007 Jan; 131(1):138-44. PubMed ID: 17227115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of clinical characteristics of extraovarian peritoneal serous papillary carcinoma with papillary serous ovarian carcinoma].
    Peng YZ; Shen K; Wu M; Huang HF; Pan LY; Yang JX; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):243-5. PubMed ID: 15924670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.